Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Zenas BioPharma, Inc. ZBIO

Set alert

Price alert · ZBIO

All alert types
27.69 USD -0.70 -2.47%

As of Nov 2, 2:53 PM ET

Bid
27.65 × 2
Ask
27.73 × 1
27.15 Day range 28.81
13.50 52-week range 44.60
YTD
-23.74%
1 year
-11.39%
Open
28.47
Prev close
28.39
Mkt cap
1.80B
Vol
234.62K
Avg vol
647.94K
EPS
-9.63
P/E
0.00
Div yield
0.00%
More statistics
Low
27.15
High
28.81
Forward P/E
-6.09
Beta
-0.88
Short ratio
17.28
Inst. own
101.23%
Dividend
0.00
Ex-div date
Earnings
Nov 18, 2026
50-d avg
29.54
200-d avg
24.93
1y target
47.88

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for ZBIO has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-0.61 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -4.3×
FY 2022: -5.8×FY 2023: -18.5×FY 2024: -2.2×FY 2025: -4.3×
FY 2022 5y median -5.0× FY 2025
P/S 162×
FY 2022: 0.0×FY 2023: 13.8×FY 2024: 68.4×FY 2025: 162×
FY 2022 5y median 41.1× FY 2025
P/B 6.7×
FY 2022: -3.6×FY 2023: -3.1×FY 2024: 1.1×FY 2025: 6.7×
FY 2022 5y median -1.0× FY 2025
P/FCF -9.4×
FY 2022: -10.1×FY 2023: -22.5×FY 2024: -2.9×FY 2025: -9.4×
FY 2022 5y median -9.8× FY 2025
EV/EBITDA -4.3×
FY 2022: -8.3×FY 2023: -24.1×FY 2024: -0.2×FY 2025: -4.3×
FY 2022 5y median -6.3× FY 2025
EV/Sales 159×
FY 2022: 0.0×FY 2023: 13.1×FY 2024: 4.7×FY 2025: 159×
FY 2022 5y median 8.9× FY 2025
FCF Yield -10.6%
FY 2022: -9.9%FY 2023: -4.4%FY 2024: -35.0%FY 2025: -10.6%
FY 2022 5y median -10.2% FY 2025

Profitability

Gross Margin 100.0%
FY 2022: 0.0%FY 2023: 100.0%FY 2024: -2682.8%FY 2025: 100.0%
FY 2022 5y median 50.0% FY 2025
Operating Margin -2113.8%
FY 2022: 0.0%FY 2023: -74.3%FY 2024: -3277.8%FY 2025: -2113.8%
FY 2022 5y median -1094.1% FY 2025
Net Margin -3777.4%
FY 2022: 0.0%FY 2023: -74.2%FY 2024: -3139.8%FY 2025: -3777.4%
FY 2022 5y median -1607.0% FY 2025
ROE -156.0%
FY 2022: 62.0%FY 2023: 16.4%FY 2024: -50.2%FY 2025: -156.0%
FY 2022 5y median -16.9% FY 2025
ROIC -65.6%
FY 2022: -154.5%FY 2023: -81.7%FY 2024: -52.3%FY 2025: -65.6%
FY 2022 5y median -73.6% FY 2025
ROA -98.5%
FY 2022: -159.9%FY 2023: -54.4%FY 2024: -42.4%FY 2025: -98.5%
FY 2022 5y median -76.5% FY 2025

Growth (YoY)

Revenue 100.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: -90.0%FY 2025: 100.0%
FY 2022 FY 2025
Operating Income -29.0%
FY 2022: 0.0%FY 2023: 51.3%FY 2024: -341.2%FY 2025: -29.0%
FY 2022 FY 2025
EPS (diluted) -124.5%
FY 2022: 0.0%FY 2023: 68.8%FY 2024: -287.6%FY 2025: -124.5%
FY 2022 FY 2025
Free Cash Flow -43.9%
FY 2022: 0.0%FY 2023: 55.0%FY 2024: -292.2%FY 2025: -43.9%
FY 2022 FY 2025

Financial Health

Current Ratio 5.6×
FY 2022: 2.6×FY 2023: 2.6×FY 2024: 6.2×FY 2025: 5.6×
FY 2022 5y median 4.1× FY 2025
Quick Ratio 5.6×
FY 2022: 2.6×FY 2023: 2.6×FY 2024: 6.2×FY 2025: 5.6×
FY 2022 5y median 4.1× FY 2025
Debt / Equity 0.3×
FY 2022: -0.0×FY 2023: -0.1×FY 2024: 0.0×FY 2025: 0.3×
FY 2022 5y median -0.0× FY 2025
Net Debt / EBITDA 0.1×
FY 2022: 0.9×FY 2023: 1.3×FY 2024: 2.0×FY 2025: 0.1×
FY 2022 5y median 1.1× FY 2025
Interest Coverage -28.9×
FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -28.9×
FY 2022 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2022 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31